Beam Therapeutics Inc (BEAM) PT Raised at Bernstein Following Positive Regulatory Update
Tweet Send to a Friend
Bernstein SocGen Group analyst William Pickering raised the price target on Beam Therapeutics Inc (NASDAQ: BEAM) to $41.00 (from $37.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
